MSH2 and hepatocellular carcinoma: Genomic profiling of HCC underlying VI showed that <i>LDLR</i>, <i>MSH2</i>, <i>KDM5D</i>, <i>PDE3A</i>, and <i>FOXO1</i> were frequently altered in the VI group compared to patients without VIs.